The overall 5-year survival rate of breast cancer among Iranian women: A systematic review and meta-analysis of published studies
- 12 December 2017
- journal article
- research article
- Published by SAGE Publications in Breast Disease
- Vol. 37 (2) , 63-68
Abstract
INTRODUCTION: Breast Cancer (BC) is the most prevalent cancer and the second leading cause of cancer-related death among Iranian women. A valid estimation of the 5-year survival rate can improve the current BC treatment programs. The present study aiKeywords
This publication has 21 references indexed in Scilit:
- The Incidence of Breast Cancer in Iran: A Systematic Review and Meta-AnalysisJournal of Analytical Oncology, 2016
- Breast cancer stem cells phenotype and plasma cell-predominant breast cancer independently indicate poor survivalPathology - Research and Practice, 2016
- Polychlorinated biphenyls and their association with survival following breast cancerEuropean Journal of Cancer, 2016
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Disease Free Survival among Molecular Subtypes of Early Stage Breast Cancer between 2001 and 2010 in IranAsian Pacific Journal of Cancer Prevention, 2013
- Survival Rate of Breast Cancer Based on Geographical Variation in Iran, a National StudyIranian Red Crescent Medical Journal, 2012
- Survival after treatment for breast cancer in a geographically defined populationBritish Journal of Surgery, 2004
- The outcome of treatment of breast cancer in a developing country—OmanThe Breast, 2004
- Beliefs and behaviours of Iranian teachers toward early detection of breast cancer and breast self-examinationPublic Health, 2002
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998